Designed for use in hospitals and ambulatory surgical centers, the FDR Cross may help improve workflows and efficiency for image-guided procedures.
Fujifilm Healthcare Americas Corporation has launched the FDR Cross, a portable device that combines digital radiography and fluoroscopic capabilities in one platform.
Reducing the need for additional equipment for image-guided procedures, the FDR Cross system features a unique hybrid c-arm that allows clinicians to obtain fluoroscopic imaging and radiographs from one device, according to Fujifilm Healthcare Americas Corporation. The company noted that the hybrid c-arm is part of an ergonomic design that can be wireless for up to eight hours and is more than 150 pounds lighter than conventional compact c-arms.
“ … the FDR Cross is our latest innovation in enhanced, portable imaging, designed to speed clinician workflows and improve patient care,” noted Rob Fabrizo, director of strategic marketing for medical imaging systems at Fujifilm Healthcare Americas Corporation. “The FDR Cross allows healthcare organizations to maximize equipment utilization by performing fluoroscopic verification and portable imaging with a single imaging system.”
Fujifilm Healthcare Americas Corporation said the FDR Cross will be showcased at the AHRA 50th Annual Meeting and Exposition July 10-13 in Phoenix.
The company noted that other features of the FDR Cross include the use of a 17 x 17-inch detector, which reportedly doubles the imaging area size in comparison to other c-arm devices. An interchangeable detector holder also enables radiologists and clinicians to switch between three different detector sizes to accommodate different exams and procedures in the OR, according to Fujifilm Healthcare Americas Corporation.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Shows Benefits of AI in Detecting Lung Cancer Risk in Non-Smokers
November 22nd 2023Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.